Longitude Prize on ALS

The Longitude Prize On ALS is an international programme incentivizing AI-based approaches to transform drug discovery for the treatment of amyotrophic lateral sclerosis (ALS). The five-year prize will see multidisciplinary teams compete in a three-phased programme to identify, prioritise and validate high-potential drug targets for ALS. To drive discovery, we have brought together a range of ALS datasets, working with data holders worldwide. The Prize is principally funded by the Motor Neurone Disease Association (MND Association), and designed and delivered by Challenge Works (supported by Nesta). Additional funders include Nesta, the Alan Davidson Foundation, My Name’5 Doddie Foundation, LifeArc, Fight MND, The 10,000 Brains Project, Answer ALS and The Packard Center at Johns Hopkins University. Learn more on our website and follow us for updates.